Today is World Cancer Day #WCD2023 Our #remotemonitoring technology is supporting people through #cancer treatment and post-treatment management of symptoms. You can read more here: https://t.co/WISkpJwalY @CR_UK
@LesleyLesleys This echoes the work by @roma_maguire in the Real-time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/bWoPwFeAey #leadership
RT @UCD_Research: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSM…
RT @UCD_Research: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSM…
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) @adarleyresearch https://t.co/OGqqFdPKZf #UCD #Research https://t.co/MmKkGjUvDp
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Real time remote symptom monitoring during chemotherapy for cancer >> Significant reduction in symptom burden in European multicentre randomised controlled trial (eSMART) https://t.co/dvxW5ypKko
Monitoreo remoto y en tiempo real de los efectos secundarios durante la quimioterapia contra el cáncer, lo que sabemos: https://t.co/gaP42Qw6Yp https://t.co/d6NB13hbXp
Monitoramento remoto e em tempo real de efeitos colaterais durante a quimioterapia para câncer, o que sabemos: https://t.co/mnEiWZE9Fk https://t.co/DPz9QJ5aqX
Ny og spennende måte å kommunisere symptomer, @SimoneKienlin. Aktuell behandlingsmetode også utenfor kreftbehandling.
Dette har vært lærerikt! Takk til @GeirBerg for muligheten. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/erhr52BoUy
RT @StrathclydeOA: Real time remote #symptom monitoring during #chemotherapy for #cancer : European multicentre randomised controlled trial…
RT @IBMScience: 🧪🖥 Should we be monitoring patients' disease progression remotely using digital tools more often? A new study has found t…
RT @healthr10: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART…
RT @healthr10: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART…
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) #wearables #digitalhealth #remotepatientmonitoring https://t.co/0WngJyx8HS
RT @IBMScience: 🧪🖥 Should we be monitoring patients' disease progression remotely using digital tools more often? A new study has found t…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Remote monitoring for chemo patients, CGM, BP hypertension, arrhythmias, all great ideas that can be linked to smartphone apps
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/SQZ9fqmncL
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJresearch https://t.co/8t4XNKoEFe @roma_maguire
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
化学療法中のスマホモニタリングで、症状軽減。3割が脱落するのを多いと見るかどうか。 https://t.co/qdUYdQJqJc
Real time remote symptom monitoring during #chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/nY7Cyw0dv4 #Cancer
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
RT @drkpavithran: Remote symptom monitoring of chemotherapy patients can reduce symptom burden and improve quality of life https://t.co/7ob…
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
RT @DHPSP: “Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the…
“Remote monitoring systems will be vital for future services, particularly with blended models of care delivery arising from the covid-19 pandemic” BMJ full text open access: https://t.co/3snAKlqha3 #HospitalsTalkToLovedOnes #quote
I remember helping to start the pilot work for this trial @setrust o I want to say almost 10 years ago... great to see this coming through such robust assessment & roll out EU wide @roma_maguire #NursingInnovation #digitalhealth #leadership https://t
RCT: Real time remote symptom monitoring during chemotherapy for cancer may reduce symptom burden and improve quality of life. – via @bmj_latest https://t.co/vlJb7CAWRK Commentary: https://t.co/XhBcYEBODW
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @IBMScience: 🧪🖥 Should we be monitoring patients' disease progression remotely using digital tools more often? A new study has found t…
RT @IBMScience: 🧪🖥 Should we be monitoring patients' disease progression remotely using digital tools more often? A new study has found t…
🧪🖥 Should we be monitoring patients' disease progression remotely using digital tools more often? A new study has found that 24 hour monitoring for cancer patients helps to better manage symptom burden and improves quality of life during chemotherapy: ht
Real time remote #symptom monitoring during #chemotherapy for #cancer : European multicentre randomised controlled trial (eSMART) https://t.co/Oo06YRoqpx #digitalhealth #healthcare #BMJresearch #eSMART #OpenAccess @StrathCIS @roma_maguire @Lisa_McCann_ @M
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @drkpavithran: Remote symptom monitoring of chemotherapy patients can reduce symptom burden and improve quality of life https://t.co/7ob…
Remote symptom monitoring of chemotherapy patients can reduce symptom burden and improve quality of life https://t.co/7obwHuNdqe https://t.co/LqCCNPuCOh
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
RT @cpgale3: Real time remote patient reported symptoms & signs + clinician alert for #chemotherapy toxicity appears to result in improved…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
The start of remote monitoring of patients receiving chemotherapy here in Stockport has been received well by patients. https://t.co/S4Bzi7ADNq
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJresearch https://t.co/R6MZ64uvuR @roma_maguire
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
Real time remote patient reported symptoms & signs + clinician alert for #chemotherapy toxicity appears to result in improved symptom burden & experience: Single blind RCT among non-metastatic #cancer participants by @roma_maguire @bmj_latest (eSM
RT @drol007: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)…
RT @bogda_koczwara: Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicent…
Significant reduction of symptoms and distress through real time remote symptom monitoring while on chemo - a multicentre RCT results from 5 European countries. https://t.co/m6orUa8zUt https://t.co/IvByT4Ew6V
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
RT @Maherjane: Hooray !
RT @Maherjane: Hooray !
RT @drol007: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)…
Hooray !
RT @drol007: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)…
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/rWx2byZHEz music 🎼 to my ears @t1mwilliams @Maherjane @MyClinOutcomes nice to see in the @bmj_latest where #proms bel
RT @nursGK704: Our new paper out @esmart_eu! PROM-based remote symptom monitoring is linked to statistically significant and clinically imp…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…